image
Healthcare - Medical - Devices - NASDAQ - US
$ 7.75
1.04 %
$ 322 M
Market Cap
-7.52
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one VREX stock under the worst case scenario is HIDDEN Compared to the current market price of 7.75 USD, Varex Imaging Corporation is HIDDEN

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one VREX stock under the base case scenario is HIDDEN Compared to the current market price of 7.75 USD, Varex Imaging Corporation is HIDDEN

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one VREX stock under the best case scenario is HIDDEN Compared to the current market price of 7.75 USD, Varex Imaging Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart VREX

image
$16.0$16.0$15.0$15.0$14.0$14.0$13.0$13.0$12.0$12.0$11.0$11.0$10.0$10.0$9.0$9.0$8.0$8.0$7.0$7.0$6.0$6.0Jan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '2515 Jun15 Jun
FINANCIALS
811 M REVENUE
-9.22%
32.1 M OPERATING INCOME
-58.37%
-47.2 M NET INCOME
-96.92%
47.3 M OPERATING CASH FLOW
-56.37%
-27.5 M INVESTING CASH FLOW
38.75%
-3.3 M FINANCING CASH FLOW
-1550.00%
213 M REVENUE
6.56%
22.1 M OPERATING INCOME
97.32%
7.1 M NET INCOME
7200.00%
16.6 M OPERATING CASH FLOW
74.74%
14.7 M INVESTING CASH FLOW
590.00%
-700 K FINANCING CASH FLOW
-0.56%
Balance Sheet Varex Imaging Corporation
image
Current Assets 650 M
Cash & Short-Term Investments 200 M
Receivables 158 M
Other Current Assets 292 M
Non-Current Assets 567 M
Long-Term Investments 26.8 M
PP&E 182 M
Other Non-Current Assets 359 M
16.47 %12.96 %23.97 %14.93 %29.47 %Total Assets$1.2b
Current Liabilities 196 M
Accounts Payable 59.1 M
Short-Term Debt 50.3 M
Other Current Liabilities 86.5 M
Non-Current Liabilities 472 M
Long-Term Debt 420 M
Other Non-Current Liabilities 51.8 M
8.85 %7.53 %12.95 %62.91 %7.76 %Total Liabilities$667.8m
EFFICIENCY
Earnings Waterfall Varex Imaging Corporation
image
Revenue 811 M
Cost Of Revenue 554 M
Gross Profit 257 M
Operating Expenses 225 M
Operating Income 32.1 M
Other Expenses 79.3 M
Net Income -47.2 M
900m900m800m800m700m700m600m600m500m500m400m400m300m300m200m200m100m100m00(100m)(100m)811m(554m)257m(225m)32m(79m)(47m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
31.68% GROSS MARGIN
31.68%
3.96% OPERATING MARGIN
3.96%
-5.88% NET MARGIN
-5.88%
-8.91% ROE
-8.91%
-3.92% ROA
-3.92%
-28.28% ROIC
-28.28%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Varex Imaging Corporation
image
90m90m80m80m70m70m60m60m50m50m40m40m30m30m20m20m10m10m00(10m)(10m)(20m)(20m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -47.2 M
Depreciation & Amortization 31.1 M
Capital Expenditures -26.9 M
Stock-Based Compensation 15.3 M
Change in Working Capital 2 M
Others 1 M
Free Cash Flow 20.4 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Varex Imaging Corporation
image
VREX has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 13
6. Ownership
Insider Ownership Varex Imaging Corporation
image
Sold
0-3 MONTHS
20 K USD 1
3-6 MONTHS
150 K USD 2
6-9 MONTHS
0 USD 0
9-12 MONTHS
32.3 K USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
207 K USD 1
9-12 MONTHS
7. News
Varex to Present at the Jefferies Global Healthcare Conference SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the Jefferies Global Healthcare Conference in New York. Management will be presenting on Wednesday, June 4, 2025 at 8:10am ET. The webcast can be accessed here or on Varex's website at www.vareximaging.com/news. About Varex Varex Imaging Corporation is a leading innovator, designer, and manufacturer of X-ray imaging components, which include X-ray tubes, digital d. businesswire.com - 1 month ago
Varex Imaging Corporation (VREX) Q2 2025 Earnings Call Transcript ConocoPhillips Company (COP) Q2 2025 - Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Christopher Belfiore - Director, IR Sunny Sanyal - President and CEO Shubham Maheshwari - CFO Conference Call Participants Young Li - Jefferies Larry Solow - CJS Securities Brandon Carney - B. Riley Securities Operator Greetings, and welcome to the Varex Q2 Fiscal Year 2025 Call. seekingalpha.com - 1 month ago
VAREX IMAGING (VREX) Reports Q2 Earnings: What Key Metrics Have to Say Although the revenue and EPS for VAREX IMAGING (VREX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com - 1 month ago
VAREX IMAGING (VREX) Q2 Earnings and Revenues Beat Estimates VAREX IMAGING (VREX) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.16 per share a year ago. zacks.com - 1 month ago
Varex Announces Financial Results for Second Quarter Fiscal Year 2025 SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the second quarter of fiscal year 2025. 2QFY25 Summary Revenues of $213 million GAAP gross margin 36% | Non-GAAP gross margin* 36% GAAP operating margin 10% | Non-GAAP operating margin* 12% GAAP net earnings $0.17 per diluted share | Non-GAAP net earnings* $0.26 per diluted share Cash flow from operations was $17 million Sunny Sanyal, Chief Executive Officer, stated, "De. businesswire.com - 1 month ago
Varex Schedules Second Quarter Fiscal Year 2025 Earnings Release and Conference Call SALT LAKE CITY--(BUSINESS WIRE)--Q2FY25 earnings date & time announcement. businesswire.com - 2 months ago
VAREX IMAGING (VREX) Moves 16.5% Higher: Will This Strength Last? VAREX IMAGING (VREX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road. zacks.com - 2 months ago
Should Value Investors Buy VAREX IMAGING (VREX) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com - 4 months ago
Varex Imaging Corporation (VREX) Q1 2025 Earnings Call Transcript Varex Imaging Corporation (NASDAQ:VREX ) Q1 2025 Earnings Conference Call February 6, 2024 5:00 PM ET Company Participants Christopher Belfiore - Director, IR Sunny Sanyal - President and CEO Shubham Maheshwari - CFO Conference Call Participants Young Li - Jefferies Kyle Bauser - B. Riley Securities Larry Solow - CJS Securities Suraj Kalia - Oppenheimer James Sidoti - Sidoti & Company Operator Greetings and welcome to the Varex First Quarter Fiscal Year 2025 Earnings Call and Webcast. seekingalpha.com - 4 months ago
VAREX IMAGING (VREX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates Although the revenue and EPS for VAREX IMAGING (VREX) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com - 4 months ago
VAREX IMAGING (VREX) Q1 Earnings Surpass Estimates VAREX IMAGING (VREX) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.06 per share a year ago. zacks.com - 4 months ago
Varex Announces Financial Results for First Quarter Fiscal Year 2025 SALT LAKE CITY--(BUSINESS WIRE)--Q1FY25 Earnings Release. businesswire.com - 4 months ago
8. Profile Summary

Varex Imaging Corporation VREX

image
COUNTRY US
INDUSTRY Medical - Devices
MARKET CAP $ 322 M
Dividend Yield 0.00%
Description Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys. This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.
Contact 1678 South Pioneer Road, Salt Lake City, UT, 84104 https://www.vareximaging.com
IPO Date Jan. 23, 2017
Employees 2300
Officers Mr. Andrew J. Hartmann Senior Vice President & GM of X-ray Detectors Mr. Christopher John Belfiore Director of Investor Relations Ms. Kimberley E. Honeysett J.D. Chief Legal Officer, General Counsel & Corporate Secretary Mr. Mark S. Jonaitis Senior Vice President & GM of X-Ray Sources Ms. Karen Aranki Chief Human Resources Officer Mr. Sunny S. Sanyal President, Chief Executive Officer & Director Mr. Shubham Maheshwari Chief Financial Officer & Principal Accounting Officer Mr. Shaohua Liang Vice President & MD for China